- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
DHS closes ultrasound acquisition
Imaging services firm Diagnostic Health Services of Dallas announced last month that it has closed its acquisition of the ultrasound division of Diagnostic Imaging Services of Los Angeles. The division was acquired for a combination of $7.5 million in
Imaging services firm Diagnostic Health Services of Dallas announced last month that it has closed its acquisition of the ultrasound division of Diagnostic Imaging Services of Los Angeles. The division was acquired for a combination of $7.5 million in cash and assumption of $1.5 million in debt.
The deal completes the first part of a transaction between Diagnostic Health and DIS that was announced earlier this year (SCAN 1/22/97). In the second part of the acquisition, Diagnostic Health will buy four hospital-based MRI centers owned by DIS. DHS estimates that the ultrasound and MRI acquisitions will add $11 million in revenues to the company.
In other Diagnostic Health news, the company last month reported financial results for 1996 that show revenues rising 41%. For the year, DHS posted revenues of $24.2 million, compared with $17.1 million in 1995. The company's net income was $2.5 million, compared with $1.2 million the year before.
DHS chairman and CEO Max Batzer said that the DIS acquisitions, along with several other of the company's purchases, will bring the company to a run rate of approximately $50 million for 1997.
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
January 3rd 2025Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
